Caitlin Reinhart

Caitlin Reinhart currently serves as the Manager of Global Pharmacovigilance and Risk Management at Bausch Health Companies Inc., a position held since October 2022. Prior to this role, Caitlin accumulated a diverse set of experiences at Seagen from January 2018 to October 2022, working as a Quality Assurance Specialist, Safety Systems Specialist in Global Safety and Risk Management, and Biomarker Data Specialist II. Earlier experience includes positions at BioLife Solutions, Inc. as Quality Control Supervisor, Quality Control Lead, and Quality Control Analyst from June 2014 to January 2018, as well as a contract role as Quality Control Analyst at Genzyme, a Sanofi Company, from January 2013 to June 2014. Caitlin holds a Bachelor of Science in Biology/Biological Sciences from Virginia Tech, awarded in 2012, and also attended Shoreline Community College in 2015.